| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 17th February 2021 | Alexandria Forbes | 15,000 | Open or private sale | $15.57 | $233,550.00 |
| 16th February 2021 | Alexandria Forbes | 15,000 | Open or private sale | $15.60 | $234,000.00 |
| 15th February 2021 | Nicole Seligman | 5,718 | Exercise of derivative | $0.00 | |
| 15th February 2021 | Nicole Seligman | 104 | Grant/award etc. | $0.00 | |
| 8th February 2021 | Advisors Llc Perceptive | 1,250,000 | Open or private purchase | $16.00 | $20,000,000.00 |
| 8th February 2021 | Advisors Llc Perceptive | 1,770,600 | Conversion of derivative | $0.00 | |
| 8th February 2021 | Advisors Llc Perceptive | 2,941,769 | Conversion of derivative | $0.00 | |
| 8th February 2021 | Advisors Llc Perceptive | 2,857,795 | Conversion of derivative | $0.00 | |
| 28th January 2021 | Advisors Llc Perceptive | 4,219,409 | Open or private purchase | $2.37 | $9,999,999.33 |
| 25th January 2021 | Advisors Llc Perceptive | 311,111 | Open or private purchase | $22.50 | $6,999,997.50 |
Meira G Tx Holdings Plc
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
MeiraGTx Holdings Plc is a clinical-stage biotech company. It engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Ticker: MGTX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1735438
Employees: 157
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $195 M (-14%)
Other Assets, Current: $2 M (-5%)
Assets, Current: $235 M (-12%)
Property, Plant and Equipment, Net: $28 M (16%)
Other Assets, Noncurrent: $194 Th (0%)
Assets: $291 M (-10%)
Accounts Payable, Current: $3 M (-17%)
Accrued Liabilities, Current: $18 M (0%)
Liabilities, Current: $47 M (-5%)
Liabilities: $118 M (-11%)
Common Stock, Value, Issued: $1 Th (1%)
Common Stock, Shares, Issued: $37 M (1%)
Retained Earnings (Accumulated Deficit): $244 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $3 M (48%)
Stockholders' Equity (Parent): $173 M (0%)
Liabilities and Equity: $291 M (-10%)
Revenue: $2 M (-62%)
Research and Development: $16 M (-33%)
General and Administrative Expenses: $11 M (-50%)
Operating Income/Loss: $25 M (-38%)
Provision for income taxes: $91 Th (0%)
